Can extremely high HDL be bad for my health?

While HDL is known as "good" cholesterol, extremely high levels (above 80-100 mg/dL) may paradoxically increase cardiovascular risk due to dysfunctional HDL particles or genetic factors. Regular testing and evaluation of your complete lipid profile is essential for understanding your true heart disease risk.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding HDL Cholesterol: The "Good" Cholesterol

High-density lipoprotein (HDL) cholesterol has long been celebrated as the "good" cholesterol, earning its reputation by helping remove excess cholesterol from your arteries and transporting it to your liver for disposal. This protective mechanism has led many to believe that when it comes to HDL, more is always better. However, emerging research suggests that extremely high HDL levels might not be the cardiovascular shield we once thought they were.

HDL particles act like tiny garbage trucks in your bloodstream, collecting cholesterol deposits from your artery walls and preventing the formation of dangerous plaques. This process, called reverse cholesterol transport, is why higher HDL levels have traditionally been associated with lower heart disease risk. But recent studies have revealed that the relationship between HDL and heart health is more complex than a simple numbers game.

What Are Normal vs. Extremely High HDL Levels?

Understanding where your HDL levels fall on the spectrum is crucial for assessing your cardiovascular health. Here's what the numbers mean:

HDL Cholesterol Levels and Cardiovascular Risk

HDL Level (mg/dL)CategoryCardiovascular RiskClinical Significance
<40 (men) <50 (women)<40 (men) <50 (women)LowHigh riskMajor risk factor for heart disease
40-6040-60NormalAverage riskAcceptable but not optimal
60-8060-80HighReduced riskGenerally protective
80-10080-100Very highUnclear benefitMay need further evaluation
>100>100Extremely highPotentially increased riskInvestigate for dysfunction or genetic causes

Risk assessment should include complete lipid profile and other cardiovascular markers, not HDL alone.

  • Low HDL: Less than 40 mg/dL for men, less than 50 mg/dL for women
  • Normal HDL: 40-60 mg/dL for men, 50-60 mg/dL for women
  • High HDL: 60-80 mg/dL (generally considered protective)
  • Very high HDL: 80-100 mg/dL
  • Extremely high HDL: Above 100 mg/dL

While HDL levels above 60 mg/dL have traditionally been viewed as protective against heart disease, levels exceeding 80-100 mg/dL enter a gray area where the benefits become less clear. Some studies suggest that HDL levels above 90 mg/dL in men and 100 mg/dL in women may actually be associated with increased cardiovascular risk.

The Paradox of Extremely High HDL

The relationship between HDL and cardiovascular protection follows what researchers call a U-shaped curve. This means that both very low and very high levels may be associated with increased risk, while moderate levels offer the most protection. This paradox has puzzled scientists and led to intensive research into why extremely high HDL might be harmful.

Dysfunctional HDL Particles

Not all HDL particles are created equal. When HDL levels are extremely high, these particles may become dysfunctional, losing their ability to effectively remove cholesterol from arteries. Think of it like having many garbage trucks that look functional but have broken compactors – they're present in high numbers but can't do their job properly. This dysfunction can occur due to oxidative stress, inflammation, or genetic factors that alter HDL's structure and function.

Genetic Factors and CETP Deficiency

Some people have genetic mutations that cause extremely high HDL levels. The most common is cholesteryl ester transfer protein (CETP) deficiency, which prevents the normal transfer of cholesterol between different lipoprotein particles. While these individuals have sky-high HDL levels, studies have shown mixed results regarding their cardiovascular protection, with some research suggesting they may not have the reduced heart disease risk you'd expect from their HDL numbers alone.

Health Risks Associated with Very High HDL

Recent large-scale studies have identified several potential risks associated with extremely high HDL levels:

  • Increased all-cause mortality: Some studies show higher death rates in people with HDL above 90-100 mg/dL
  • Cardiovascular events: Paradoxically higher rates of heart attacks and strokes in some populations
  • Atrial fibrillation: Increased risk of irregular heart rhythms
  • Infectious disease mortality: Some research suggests impaired immune function with very high HDL

A landmark study published in the European Heart Journal followed over 100,000 individuals and found that those with HDL levels above 97 mg/dL in men and 116 mg/dL in women had significantly higher mortality rates compared to those with moderate HDL levels. This challenges the long-held belief that you can never have too much good cholesterol.

Common Causes of Extremely High HDL

Understanding what drives your HDL to extreme levels is crucial for determining whether it's a cause for concern. Here are the most common factors:

Lifestyle Factors

  • Excessive alcohol consumption: Regular heavy drinking can significantly raise HDL levels
  • Extreme endurance exercise: Ultra-marathoners and extreme athletes often have very high HDL
  • Certain medications: Including estrogen therapy, fibrates, and some HIV medications
  • Dietary factors: High intake of certain fats, particularly from fish and olive oil

Medical Conditions

  • Primary biliary cholangitis: A liver condition that can cause extremely elevated HDL
  • Hyperthyroidism: Overactive thyroid can increase HDL production
  • Chronic inflammation: Certain inflammatory conditions paradoxically raise HDL
  • Genetic disorders: Including CETP deficiency and familial hyperalphalipoproteinemia

If your HDL levels are extremely high, it's important to work with your healthcare provider to identify the underlying cause. This may involve additional testing beyond standard lipid panels, including genetic testing, liver function tests, and inflammatory markers. Understanding your complete cardiovascular risk profile requires looking at all your biomarkers together, not just HDL in isolation.

Beyond HDL: The Importance of Comprehensive Lipid Testing

Focusing solely on HDL levels provides an incomplete picture of your cardiovascular risk. Modern cardiovascular risk assessment has moved beyond simple cholesterol ratios to more sophisticated markers that better predict heart disease risk. Key biomarkers to consider include:

  • Apolipoprotein B (ApoB): Measures the number of atherogenic particles in your blood
  • Lipoprotein(a): A genetic risk factor for heart disease
  • High-sensitivity C-reactive protein (hs-CRP): Indicates inflammation in your arteries
  • Triglycerides: High levels can make HDL particles dysfunctional
  • LDL particle size and number: Small, dense LDL particles are more dangerous

The ratio of ApoB to ApoA1 (the main protein in HDL) provides a more accurate assessment of cardiovascular risk than traditional cholesterol ratios. This is because it measures the balance between atherogenic and anti-atherogenic particles, giving you a clearer picture of your true risk.

What to Do If You Have Extremely High HDL

If your HDL levels are above 80-90 mg/dL, here's what you should consider:

  1. Get comprehensive testing: Don't rely on HDL alone – get a full cardiovascular panel including ApoB, Lp(a), and inflammatory markers
  2. Review medications and supplements: Some can artificially elevate HDL without providing cardiovascular benefit
  3. Assess alcohol intake: If you drink heavily, reducing consumption may normalize HDL levels
  4. Evaluate exercise patterns: While exercise is beneficial, extreme endurance training can push HDL to very high levels
  5. Consider genetic testing: If levels are extremely high (>100 mg/dL), genetic factors may be at play
  6. Focus on overall cardiovascular health: Maintain healthy blood pressure, blood sugar, and body weight

Remember that cardiovascular risk is multifactorial. Even with high HDL, you need to address other risk factors like smoking, diabetes, hypertension, and obesity. A comprehensive approach to heart health is always more effective than focusing on a single biomarker.

The Future of HDL Research and Testing

The field of lipidology is rapidly evolving, with new research challenging old assumptions about cholesterol and heart disease. Scientists are now focusing on HDL functionality rather than just quantity, developing tests that can measure how well your HDL particles perform their cholesterol-clearing duties. These functional assays may soon become part of routine cardiovascular risk assessment.

Additionally, researchers are investigating HDL subfractions – different types of HDL particles that may have varying effects on cardiovascular health. Large, buoyant HDL2 particles appear more protective than small, dense HDL3 particles. Understanding your HDL composition, not just total levels, may provide better insight into your cardiovascular risk.

Taking Control of Your Cardiovascular Health

While extremely high HDL levels can be concerning, they're just one piece of the cardiovascular puzzle. The key is to understand your complete lipid profile and overall cardiovascular risk factors. Regular monitoring through comprehensive biomarker testing allows you to track changes over time and assess how lifestyle modifications or treatments are affecting your heart health.

The paradox of extremely high HDL reminds us that more isn't always better when it comes to biomarkers. What matters most is achieving balance across all your cardiovascular risk factors and maintaining HDL levels in the optimal range – high enough to provide protection but not so high that functionality is compromised. By taking a comprehensive approach to testing and understanding your results in context, you can make informed decisions about your cardiovascular health and work with your healthcare provider to develop an effective prevention strategy.

Frequently Asked Questions

References

  1. Madsen, C. M., Varbo, A., & Nordestgaard, B. G. (2017). Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. European Heart Journal, 38(32), 2478-2486.[Link][PubMed][DOI]
  2. Ko, D. T., Alter, D. A., Guo, H., et al. (2016). High-density lipoprotein cholesterol and cause-specific mortality in individuals without previous cardiovascular conditions. Journal of the American College of Cardiology, 68(19), 2073-2083.[PubMed]
  3. Zanoni, P., Khetarpal, S. A., Larach, D. B., et al. (2016). Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease. Science, 351(6278), 1166-1171.[PubMed]

Frequently Asked Questions

How can I test my HDL cholesterol at home?

You can test your HDL cholesterol at home with SiPhox Health's Heart & Metabolic Program. This CLIA-certified program includes HDL testing along with comprehensive cardiovascular biomarkers like ApoB, triglycerides, and inflammatory markers, providing lab-quality results from the comfort of your home.

What HDL level is considered too high?

HDL levels above 80-90 mg/dL may enter a zone of concern, with some studies showing increased cardiovascular risk above 90 mg/dL in men and 100 mg/dL in women. Extremely high HDL above 100 mg/dL warrants further investigation to determine the underlying cause and assess whether the HDL particles are functioning properly.

Can lifestyle changes lower extremely high HDL?

Yes, certain lifestyle modifications can help normalize very high HDL levels. Reducing excessive alcohol consumption, moderating extreme endurance exercise, and reviewing medications with your doctor can all impact HDL levels. However, if genetic factors are involved, lifestyle changes may have limited effect.

Should I be worried if my HDL is over 100 mg/dL?

HDL levels over 100 mg/dL warrant discussion with your healthcare provider. While not immediately dangerous, extremely high HDL may indicate dysfunctional HDL particles, genetic conditions, or other underlying issues. Comprehensive cardiovascular testing including ApoB and inflammatory markers can provide better insight into your actual risk.

What other tests should I get if my HDL is very high?

If your HDL is extremely high, consider testing ApoB, Lipoprotein(a), hs-CRP, comprehensive thyroid panel, and liver function tests. These markers provide a complete picture of your cardiovascular risk and can help identify underlying causes of elevated HDL. Genetic testing may also be recommended for very high levels.

Related Articles

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details